09:30 AM EDT, 10/10/2025 (MT Newswires) -- VolitionRx ( VNRX ) said Friday it priced an underwritten public offering of 11.6 million shares and warrants to purchase 11.6 million shares at $0.52 per share and accompanying warrant.

Underwriters were granted a 30-day option to buy up to an additional 1.7 million shares together with warrants to purchase 1.7 million shares, the company said.

Each warrant has an exercise price of $0.60 per share, is exercisable immediately, and expires in five years, the company said.

Gross proceeds, excluding the exercise of warrants and the underwriter's option, are expected to be about $6 million, the company said.

The offering is expected to close on Tuesday.

VolitionRx ( VNRX ) shares were down by more than 16% in premarket trading.